Enteral formulation
View Patent ↗A formulation for enteral administration to a patient is disclosed.
1. A formulation for enteral administration to a patient, comprising:
from about 1 gram to about 5 grams of Arginine per 240 calories of said formulation;
from about 1.5 grams to about 7.5 grams of glutamine per 240 calories of said formulation;
from about 1 gram to about 5.5 grams of Proline per 240 calories of said formulation; and
from about 2.4 grams to about 9 grams of branched chain amino acids per 240 calories of said formulation.
2. The formulation of claim 1 , wherein:
said branched chain amino acids include Leucine, Isoleucine, or Valine.
3. The formulation of claim 1 , further comprising:
Pycnogenol.
4. The formulation of claim 1 , further comprising:
Alpha-Lipoic acid.
5. The formulation of claim 1 , further comprising:
an Oxerutin.
6. The formulation of claim 1 , further comprising:
a triterpene glycoside.
7. The formulation of claim 1 , further comprising:
Coenzyme Q10.
8. The formulation of claim 1 , further comprising:
N-acetyl-cycteine.
9. The formulation of claim 1 , further comprising:
a triglyceride containing two residues of the same fatty acid selected from the group consisting of eicosapentaenoic acid or gamma-linolenic acid.
10. A formulation for enteral administration to a patient, comprising:
Pycnogenol, Alpha-Lipoic acid, Oxerutin, a triterpene glycoside, Coenzyme Q10, and N-acetyl-cycteine.
11. The formulation of claim 10 , further comprising:
from about 1 gram to about 5 grams of Arginine per 240 calories of said formulation;
from about 1.5 grams to about 7.5 grams of glutamine per 240 calories of said formulation;
from about 1 gram to about 5.5 grams of Proline per 240 calories of said formulation; and
from about 2.4 grams to about 9 grams of branched chain amino acids per 240 calories of said formulation.
12. The formulation of claim 11 , wherein:
said branched chain amino acids include Leucine, Isoleucine, or Valine.
13. The formulation of claim 10 , further comprising:
a triglyceride containing two residues of the same fatty acid selected from the group consisting of eicosapentaenoic acid or gamma-linolenic acid.